Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
about
The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsSUMOylation of the Forkhead transcription factor FOXL2 promotes its stabilization/activation through transient recruitment to PML bodiesThe forkhead transcription factor Foxl2 is sumoylated in both human and mouse: sumoylation affects its stability, localization, and activity.Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammalA novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcriptionNovel action of FOXL2 as mediator of Col1a2 gene autoregulation.Exportin 4 interacts with Sox9 through the HMG Box and inhibits the DNA binding of Sox9.Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes.Cartilage-specific over-expression of CCN family member 2/connective tissue growth factor (CCN2/CTGF) stimulates insulin-like growth factor expression and bone growth.SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1)The versatile functions of Sox9 in development, stem cells, and human diseasesIdentification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-α expression upon lipopolysaccharide stimulation in human monocytes.Interactions between SOX factors and Wnt/beta-catenin signaling in development and diseaseElp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.Phosphorylation of Sox9 is required for neural crest delamination and is regulated downstream of BMP and canonical Wnt signaling.Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering.E6-AP/UBE3A protein acts as a ubiquitin ligase toward SOX9 protein.Protein-protein interactions: principles, techniques, and their potential role in new drug development.Unraveling the transcriptional regulatory machinery in chondrogenesis.A role for estrogen in somatic cell fate of the mammalian gonad.The chondrocytic journey in endochondral bone growth and skeletal dysplasia.A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6.SOX9 and the many facets of its regulation in the chondrocyte lineage.PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.RNA binding proteins regulate anabolic and catabolic gene expression in chondrocytes.Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro.Arid5b facilitates chondrogenesis by recruiting the histone demethylase Phf2 to Sox9-regulated genes.THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis.SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity.Phosphorylation Modulates the Subcellular Localization of SOX11.
P2860
Q24647979-586D9B79-B4FD-4207-8EFB-DCCE18B77CD1Q24676478-D8A48A6E-4520-44A2-814C-A51BE201B237Q28477459-5E5E5D0A-FEAB-49A4-B184-60C013234000Q29871426-98689461-E72E-4894-888E-C09054A0581BQ33679345-BD107C78-5A89-43F2-84A7-66F7A9C0FF38Q33799771-F136CD18-CABE-45D8-84BA-1004D9215C8AQ33926240-3AEC5CA3-119C-4B44-A75B-FC91E743FB22Q34047075-D245450F-9F46-43FA-B546-A0C8A9A00136Q34343807-CB783F3D-7777-4BBD-A5DE-78109D212F72Q34650896-456E3C30-BA6D-4ABA-A1AB-69B4CE015936Q34999271-58C75E6E-374C-45CB-8309-CDFC1EF24573Q35077784-8882702E-9D7C-4FB9-95B4-2653A1F2CE69Q35244113-5984D5AC-5FD5-46EA-88AF-E0194F837457Q35719925-D7451715-AC94-4EB0-A9A2-B28B22BA57DEQ36286025-19AB1A3B-E489-406E-B277-D70397BF7AB4Q36637429-2A57398B-0970-4B5F-8CAD-25C8C980A0ECQ36676468-5B4EA01C-542D-4080-8BD9-A277A820EF90Q37343393-DE5EE956-F7E1-4889-B6D5-9918B3651E05Q37368635-47EA354C-13DB-4AAF-8E8E-BC2DA76F08FDQ37862224-157AEE0F-C83E-460C-835A-E188F1D16AAFQ37877164-4CEE2059-3069-489A-B572-B5DD93D36A1AQ37967475-FB7176D3-9511-4727-A049-8266708E6862Q38200066-F89F4584-661D-4449-A19F-616F59178D3DQ38729196-63B9E620-539A-478A-8072-5714FCBAB686Q38820782-1EB1F17F-09BF-4C02-929A-E876196F2599Q40141737-42D90029-5974-41C5-934F-73024885E4F0Q41977523-467C846D-AD56-4A10-ADB3-A317D5D11051Q42262285-ACA4704E-B69B-4AEF-B10C-D7079017B1A0Q42810019-2D3D547A-A6ED-4CB4-8C39-B518ACB208A8Q47997205-21928498-C9D4-4504-A20F-5F5C13C1CAD2Q52592784-C3C5A392-0C90-4A86-9204-B870BEC9FC27Q55411224-C2429215-0A49-4963-8BF3-4E0F7A644E44
P2860
Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interactions between PIAS prot ...... llular concentrations of SOX9.
@ast
Interactions between PIAS prot ...... llular concentrations of SOX9.
@en
type
label
Interactions between PIAS prot ...... llular concentrations of SOX9.
@ast
Interactions between PIAS prot ...... llular concentrations of SOX9.
@en
prefLabel
Interactions between PIAS prot ...... llular concentrations of SOX9.
@ast
Interactions between PIAS prot ...... llular concentrations of SOX9.
@en
P2093
P2860
P356
P1476
Interactions between PIAS prot ...... llular concentrations of SOX9.
@en
P2093
Benoit de Crombrugghe
Heidi Eberspaecher
Hideyo Yasuda
Jingfang Lu
Takako Hattori
Tamotsu Nishida
Tomoaki Kahyo
P2860
P304
14417-14428
P356
10.1074/JBC.M511330200
P407
P577
2006-03-21T00:00:00Z